OmniAb, Inc. SEC filings OABI
OmniAb, Inc. has 387 filings in SEC EDGAR's recent list, going back to Mar 19, 2021. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Sep 19, 2025 | — |
| CORRESP | Letter to the SEC | Sep 17, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 16, 2025 | — |
| D | Filing | Sep 10, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 27, 2024 | — |
| CORRESP | Letter to the SEC | Sep 24, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 11, 2024 | — |
| EFFECT | Filing | Dec 18, 2023 | — |
| EFFECT | Filing | Dec 18, 2023 | — |
| CORRESP | Letter to the SEC | Dec 14, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 13, 2023 | — |
| EFFECT | Filing | May 10, 2023 | — |
| POS EX | Filing | Mar 31, 2023 | — |
| EFFECT | Filing | Feb 10, 2023 | — |
| CORRESP | Letter to the SEC | Feb 8, 2023 | — |
| CORRESP | Letter to the SEC | Feb 6, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 19, 2023 | — |
| CORRESP | Letter to the SEC | Jan 5, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 19, 2022 | — |
| 25-NSE | Delisting notice | Nov 1, 2022 | — |
| 425 | Filing | Oct 3, 2022 | — |
| 425 | Filing | Oct 3, 2022 | — |
| EFFECT | Filing | Sep 30, 2022 | — |
| CORRESP | Letter to the SEC | Sep 28, 2022 | — |
| CORRESP | Letter to the SEC | Sep 27, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 21, 2022 | — |
| SEC STAFF LETTER | Filing | Sep 16, 2022 | — |
| CORRESP | Letter to the SEC | Sep 12, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 7, 2022 | — |
| 425 | Filing | Aug 24, 2022 | — |
| CORRESP | Letter to the SEC | Aug 22, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 15, 2022 | — |
| CORRESP | Letter to the SEC | Jul 26, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2022 | — |
| 425 | Filing | Jun 21, 2022 | — |
| CORRESP | Letter to the SEC | Jun 10, 2022 | — |
| SEC STAFF LETTER | Filing | May 31, 2022 | — |
| UPLOAD | Letter from the SEC | May 27, 2022 | — |
| NT 10-Q | Filing | May 16, 2022 | Mar 31, 2022 |
| 425 | Filing | May 5, 2022 | — |
| DEL AM | Filing | Apr 29, 2022 | — |
| 425 | Filing | Mar 24, 2022 | — |
| 425 | Filing | Mar 23, 2022 | — |
| CERT | Filing | Aug 10, 2021 | — |
| EFFECT | Filing | Aug 9, 2021 | — |
| 8-A12B | Filing | Aug 9, 2021 | — |
| CORRESP | Letter to the SEC | Aug 5, 2021 | — |
| CORRESP | Letter to the SEC | Aug 5, 2021 | — |
| CORRESP | Letter to the SEC | Jul 28, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 6, 2021 | — |
| DRSLTR | Filing | May 12, 2021 | — |
| DRS/A | Filing | May 12, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 14, 2021 | — |
| DRS | Filing | Mar 19, 2021 | — |
Showing 54 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- OABI (Nasdaq), OABIW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Emeryville, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1846253
- Former names
- Avista Public Acquisition Corp. II (until Nov 1, 2022)
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- NRC Health NRC
- Maxcyte, Inc. MXCT
All 17 Services-Commercial Physical & Biological Research companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.